SkyWater Technology 주식 (NASDAQ: SKYT)

에 대한 최신 뉴스 SkyWater Technology (NASDAQ:SKYT) 주식

SkyWater Technology

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

What Happened

Equities

Government

Market Summary

News

Politics

Economics

Markets

Tech

General

AMKR

COHR

ENTG

INFN

INTC

MCHP

MTSI

POLA

RKLB

SKYT

WOLF

화요일(4일) 저녁 의회 합동 연설에서 도널드 트럼프 대통령은 미국에 시설을 설립하는 반도체 회사에 제조 인센티브를 제공하는 칩스법(CHIPS)의 폐지를 촉구했다. 

칩스법 폐지 시사한 트럼프...어떤 기업이 보조금 수혜 받았나?

SkyWater Technology Inc

Skytop Lodge Corp

SKYTOP LODGE CORP 7 PFD by Skytop Lodge Corp.

Earnings

Earnings Misses

CTOR

Citius Oncology Q2 EPS $(0.11) Misses $(0.09) Estimate

SS Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>) reported quarterly losses of $(0.03) per share. The company reported $5.10 million in sales this quarter.

SSII

SS Innovations Q1 EPS $(0.03), Sales $5.10M

Nauticus Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) reported quarterly losses of $(0.28) per share. The company reported $165.26 thousand in sales this quarter.

KITT

Nauticus Robotics Q1 EPS $(0.28) Up From $(3.96) YoY, Sales $165.26K Down From $464.35M YoY

Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.15) by 20 percent. This is a 91.13 percent increase over losses of $(2.03) per share from the same period last year.

CLDI

Calidi Biotherapeutics Q1 EPS $(0.18) Misses $(0.15) Estimate

Stock Split

SQFT

SQFTP

SQFTW

Presidio Property Trust Announces 1-For-10 Reverse Stock Split

- PBGENE-DMD is a first-in-class in vivo gene editing approach for the majority of Duchenne Muscular Dystrophy patients impacted by dystrophin mutations in the most common ‘hot spot' region between exons 45-55 -
- Final clinical candidate PBGENE-DMD demonstrates compelling preclinical data for durably improving functional benefit over time -
- Precision targeting to submit an Investigational New Drug (IND) and/or Clinical Trial Application (CTA) for PBGENE-DMD in 2025 with clinical data expected in 2026 -
- Precision to host a webcast and conference call on Thursday, May 15, 2025 at 8:00 AM ET -
Precision BioSciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>), a clinical stage gene editing company utilizing its novel proprietary ARCUS&#xAE; platform to develop in vivo gene editing therapies for diseases with high unmet need, today announced the strategic prioritization and acceleration of PBGENE-DMD, the Company's first-in-class in vivo gene editing approach for Duchenne Muscular Dystrophy (DMD) and highlighted a PBGENE-DMD poster presentation at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting being held May 13-17, 2025, in New Orleans, Louisiana.

Biotech

DTIL

Precision BioSciences Accelerates Development Of First-in-Class In Vivo Gene Editing Therapy PBGENE-DMD For Duchenne Muscular Dystrophy Targeting Exons 45–55 Hot Spot, IND/CTA Submission Planned For 2025 And Clinical Data Expected In 2026

Global Water Resources (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWRS#NASDAQ">GWRS</a>) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $0.01 by 100 percent. This is a 33.33 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $12.46 million which beat the analyst consensus estimate of $12.00 million by 3.81 percent. This is a 7.30 percent increase over sales of $11.61 million the same period last year.

Earnings Beats

GWRS

Global Water Resources Q1 EPS $0.02 Beats $0.01 Estimate, Sales $12.46M Beat $12.00M Estimate

Management

CSCO

Cisco Systems CFO Scott Herren To Retire Effective July 26, 2025; Mark Patterson To Succeed

First Citizens BancShares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>) has outperformed the market over the past 15 years by 4.76% on an annualized basis producing an average annual return of 16.75%. Currently, First Citizens BancShares has a market capitalization of $26.08 billion. 
Buying $100 In FCNCA: If an investor had bought $100 of FCNCA stock 15 years ago, it would be worth $984.91 today based on a price of $1962.92 for FCNCA at the time of writing.
<h3>First Citizens BancShares's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747255516_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

FCNCA

Here's How Much $100 Invested In First Citizens BancShares 15 Years Ago Would Be Worth Today

Battalion Oil (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BATL#AMEX">BATL</a>) reported quarterly losses of $(0.35) per share. This is a 84.38 percent increase over losses of $(2.24) per share from the same period last year. The company reported $47.48 million in sales this quarter. This is a 4.80 percent decrease over sales of $49.87 million the same period last year.

BATL

Battalion Oil Q1 EPS $(0.35) Up From $(2.24) YoY, Sales $47.48M Down From $49.87M YoY

BZAI

Blaize Holdings Q1 EPS $(1.61), Sales $1.01M

Oruka Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKA#NASDAQ">ORKA</a>) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.52) by 23.08 percent. This is a 81.9 percent increase over losses of $(2.21) per share from the same period last year.

ORKA

Oruka Therapeutics Q1 EPS $(0.40) Beats $(0.52) Estimate

Jade Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBIO#NASDAQ">JBIO</a>) reported quarterly losses of $(12.10) per share which missed the analyst consensus estimate of $(1.74) by 595.4 percent.

JBIO

Jade Biosciences Q1 EPS $(12.10) Misses $(1.74) Estimate

Contango Ore (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CTGO#AMEX">CTGO</a>) reported quarterly losses of $(1.88) per share which missed the analyst consensus estimate of $(0.21) by 795.24 percent. This is a 12.15 percent increase over losses of $(2.14) per share from the same period last year.

CTGO

Contango Ore Q1 EPS $(1.88) Misses $(0.21) Estimate

Aardvark Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AARD#NASDAQ">AARD</a>) reported quarterly losses of $(0.71) per share. This is a 29.09 percent decrease over losses of $(0.55) per share from the same period last year.

AARD

Aardvark Therapeutics Q1 EPS $(0.71) Down From $(0.55) YoY

Enpro Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPO#NYSE">NPO</a>) today announced the pricing of its previously announced offering of senior notes due 2033 (the "Senior Notes"). The face value of the Senior Notes is $450 million with an annual interest rate of 6.125%. The Senior Notes were priced at 100.0% of the face value. The offer was made in the United States to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to non-U.S. persons in reliance on Regulation S under the Securities Act. The Senior Notes offering is expected to close on May 29, 2025.
Enpro intends to use the net proceeds from the offering to fund the redemption of all of its outstanding 5.75% senior notes due 2026 (the "Outstanding Notes"), to repay a portion of the borrowings under its senior secured revolving credit facility used to fund the repayment on April 9, 2025 of all of its then-outstanding term loans under its senior secured credit facility, and to pay fees and expenses in connection with the offering. The conditional redemption of the Outstanding Notes was announced by Enpro on May 13, 2025.

Offerings

Enpro Inc. Prices Offering Of $450M 6.125% Senior Notes Due 2033

Enveric Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) reported quarterly losses of $(1.22) per share. This is a 86.75 percent increase over losses of $(9.21) per share from the same period last year.

ENVB

Enveric Biosciences Q1 EPS $(1.22) Up From $(9.21) YoY

Empire Petroleum (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EP#AMEX">EP</a>) reported quarterly losses of $(0.13) per share. This is a 13.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported $9.00 million in sales this quarter. This is a 4.10 percent decrease over sales of $9.39 million the same period last year.

Empire Petroleum Q1 Adj. EPS $(0.13) Up From $(0.15) YoY, Sales $9.00M Down From $9.39M YoY

Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) sees Q2 sales of $1.500 million-$1.700 million vs $1.52 million analyst estimate.

Guidance

Blaize Holdings Sees Q2 Sales $1.500M-$1.700M vs $1.52M Est

Blaize Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) affirms FY2025 sales outlook from $19.00 million-$50.00 million to $19.00 million-$50.00 million.

Blaize Holdings Affirms FY2025 Sales Guidance of $19.00M-$50.00M

Press Releases

SkyWater Technology to Announce Fourth Quarter Financial Results on February 26, 2025

SkyWater Technology Announces Earlier Availability of Fourth Quarter Financial Results and Webcast

SkyWater Technology Reports Fourth Quarter and Full Fiscal Year 2024 Results

SkyWater to Acquire Infineon's Austin Fab and Establish Strategic Partnership to Expand U.S. Foundry Capacity for Foundational Chips

SkyWater's Commercially Fabricated Qubits Power D-Wave's Landmark Achievement in Quantum Supremacy

SkyWater Expands Board of Directors with Appointment of Timothy Baxter, Tammy Miller and Andy LaFrence

SkyWater Technology to Announce First Quarter Financial Results on May 7, 2025

SkyWater Appoints Dr. Percy Gilbert as Senior Vice President of Engineering

SkyWater Technology Reports First Quarter 2025 Results

SkyWater Announces Participation in Upcoming Investor Conferences

IFNNY

QBTS

Alpha and Omega Semiconductor Limited - Common Shares

Alpha & Omega

Blaize Holdings

CEVA

Canadian Solar

GCT Semiconductor Holding, Inc. Common Stock

GCT Semiconductor Hldgs

GSI Technology

Himax Technologies, Inc. - American depositary shares, each of which represents two ordinary shares.

Himax Techs

Intchains Group Limited - American Depositary Shares

Intchains Gr

ChipMOS TECHNOLOGIES INC. - American Depositary Shares

ChipMOS TECHNOLOGIES

indie Semiconductor, Inc. - Class A Common Stock

Indie Semiconductor

JinkoSolar Holding Company Limited American Depositary Shares (each representing 4 Common Shares)

JinkoSolar Holding Co

Kopin

SEALSQ

Everspin Technologies, Inc. - Common Stock

Everspin Technologies

Magnachip Semiconductor Corporation Common Stock

MagnaChip Semiconductor

MaxLinear

Navitas Semiconductor Corporation - Common Stock

Navitas Semiconductor

Penguin Solutions, Inc. - Ordinary Shares

Penguin Solutions

QuickLogic

Silicon Motion Technology Corporation - American Depositary Shares, each representing four ordinary shares

Silicon Motion Technology

Sequans Communications S.A. American Depositary Shares (each representing ten (10) Ordinary Shares)

Sequans Communications

Toyo Co

Valens Semiconductor Ltd. Ordinary Shares

Valens Semiconductor

Wolfspeed

Needham

Piper Sandler

Craig-Hallum

Cowen & Co.

화요일(4일) 저녁 의회 합동 연설에서 도널드 트럼프 대통령은 미국에 시설을 설립하는 반도체 회사에 제조 인센티브를 제공하는 칩스법(CHIPS)의 폐지를 촉구했다.
무슨 일 있었나: 화요일의 의회 연설에서 대통령은 "칩스법은 끔찍하고 끔찍한 법안"이라며 비판했다. 트럼프는 마이크 존슨 미 하원 의장에게 이 법안을 "없애고", "남은 것은 무엇이든" "부채를 줄이거나 원하는 다른 이유"를 위해 사용하라고 촉구했다.
<a href="//www.semiconductors.org/chips-incentives-awards/"" target="_blank" rel="noopener">반도체산업협회</a>에 따르면 칩스법 프로그램은 미국 반도체 제조에 대한 투자를 촉진했다. 23개 주에 걸쳐 32개 기업에 약 380억 달러의 보조금과 대출금이 지급되었으며, 2030년까지 3800억 달러 이상의 민간 투자를 유치하고 약 145,000개의 새로운 일자리를 창출할 것으로 예상된다.
특히, 국방부와 상무부는 첨단 반도체의 국내 제조를 확대하고 국가 안보에 필수적인 미국 공급망을 강화하기 위해 인텔에 최대 30억 달러의 칩스법 자금을 지원했다.
한편, TSMC는 66억 달러 상당의 보조금을 받았으며, 그중 50억 달러는 애리조나주 피닉스에 650억 달러 규모의 프로젝트를 설립하기 위해 대출받은 금액이다.
다음은 칩스법에 따라 보조금을 받은 미국 상장 수혜 기업 목록이다.
<figure class="wp-block-table is-style-stripes">
<table style="overflow:auto; height: 90px; display: block;">
<tbody>
<tr>
<td>회사 </td>
<td>연초 대비 주가 실적</td>
<td>1년 실적</td>
</tr>
<tr>
<td>앰코 테크놀로지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>)</td>
<td>-21.57%</td>
<td>-37.79%</td>
</tr>
<tr>
<td>아나로그디바이스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADI#NASDAQ">ADI</a>)</td>
<td>7.02%</td>
<td>19.17%</td>
</tr>
<tr>
<td>코히런트 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>)</td>
<td>-30.84%</td>
<td>5.51%</td>
</tr>
<tr>
<td>코닝 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>)</td>
<td>-0.46%</td>
<td>43.05%</td>
</tr>
<tr>
<td>인테그리스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>)</td>
<td>1.15%</td>
<td>-27.49%</td>
</tr>
<tr>
<td>글로벌파운드리 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>)</td>
<td>-11.56%</td>
<td>-28.48%</td>
</tr>
<tr>
<td>HP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>)</td>
<td>-9.79%</td>
<td>0.55%</td>
</tr>
<tr>
<td>인피네라 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFN#NASDAQ">INFN</a>)</td>
<td>1.07%</td>
<td>28.93%</td>
</tr>
<tr>
<td>인텔 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)</td>
<td>5.49%</td>
<td>-50.58%</td>
</tr>
<tr>
<td>마컴 테크놀로지 솔루션스 홀딩스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>)</td>
<td>-15.20%</td>
<td>20.75%</td>
</tr>
<tr>
<td>마이크로칩 테크놀로지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>)</td>
<td>2.22%</td>
<td>-32.11%</td>
</tr>
<tr>
<td>마이크론 테크놀로지 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>)</td>
<td>4.43%</td>
<td>-3.46%</td>
</tr>
<tr>
<td>폴라 파워 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POLA#NASDAQ">POLA</a>)</td>
<td>-29.51%</td>
<td>-16.33%</td>
</tr>
<tr>
<td>로켓랩 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>)</td>
<td>-23.90%</td>
<td>348%</td>
</tr>
<tr>
<td>스카이워터 테크놀로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>)</td>
<td>-35.93%</td>
<td>-24.96%</td>
</tr>
<tr>
<td>텍사스 인스투르먼트 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>)</td>
<td>4.22%</td>
<td>14.18%</td>
</tr>
<tr>
<td>TSMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>)</td>
<td>-10.71%</td>
<td>33.36%</td>
</tr>
<tr>
<td>울프스피드 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>)</td>
<td>-20.51%</td>
<td>-80.08%</td>
</tr>
</tbody>
</table>
</figure>
이 기사도 읽어보세오: <a href="https://kr.benzinga.com/news/usa/stocks/%EB%A7%A4%EA%B7%B8-7-%EB%B9%85%ED%85%8C%ED%81%AC-%EC%A2%85%EB%AA%A9-2025%EB%85%84-sp-500-%EC%88%98%EC%9D%B5%EB%A5%A0-%EC%83%81%EC%9C%84-50%EC%9C%84-%EB%B0%96%EC%9C%BC%EB%A1%9C-%EB%B0%80/" target="_blank" rel="noopener">‘매그 7' 빅테크 종목, 2025년 S&amp;P 500 수익률 상위 50위 밖으로 밀려나</a>
왜 중요한가: 트럼프의 의회 연설 몇 시간 전, TSMC는 미국 내 첨단 반도체 제조에 1,000억 달러를 추가로 <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44124444/taiwan-semiconductor-rises-as-100-billion-u-s-expansion-defies-market-downturn" target="_blank" rel="noopener">투자할 계획이라고 발표했다.</a> 애리조나에서 이미 진행 중인 650억 달러 규모의 프로젝트를 기반으로 한 이번 투자 확대로 TSMC의 미국 내 총 투자액은 1,650억 달러에 달하게 된다.
트럼프 대통령은 TSMC의 최근 투자에 대해 이렇게 말했다. "그들에게 중요한 것은 관세를 내고 싶지 않다는 것이었다. 그래서 그들은 와서 공장을 짓고 있다. 그리고 다른 많은 회사들도 오고 있다. 우리는 그들에게 돈을 줄 필요 없이 우리 기업과 우리 국민을 보호하고 싶을 뿐이며, 그들이 미국에 지으면 관세를 내지 않아도 되기 때문에 올 것이다.&#8221;
가격 움직임: 각각 S&amp;P 500 지수와 나스닥 100 지수를 각각 추종하는 SPDR S&amp;P 500 ETF Trust(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)와 Invesco QQQ Trust ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)는 화요일에 하락했다. <a href="//pro.benzinga.com/dashboard"" target="_blank" rel="noopener">벤징가 프로</a> 데이터에 따르면 SPY는 1.18% 하락한 576.86달러, QQQ는 0.30% 하락한 495.55달러를 기록했다.
수요일 다우존스 선물은 0.47%, S&amp;P 500 선물은 0.60% 상승한 반면 나스닥 100 선물은 0.72% 상승했다.
사진 출처: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

SkyWater Technology

뉴스

에 대한 최신 뉴스 SkyWater Technology (NASDAQ:SKYT) 주식

수요일, 3월 05, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌